After going for decades with few available migraine drugs, the 25 million Americans who suffer these monster headaches now have a wide choice of new remedies.
Yet sales of migraine drugs have so far not lived up to expectations.
These studies involved triptans, a common class of migraine drugs.
They include patients with tumors that secreted serotonin and those who had taken a migraine drug, ergotamine, for long periods.
Imitrex and the other migraine drugs have lost sales as manufacturers released too many drug samples.
With its new migraine drug, for example, Glaxo was able to show fewer lost work days and improved quality of life.
No other migraine drugs have worked for me.
Your current migraine drugs are not providing sufficient relief.
The migraine drug was one of Synaptic's leading compounds.
A spokesman for Lilly said yesterday that the migraine drug was dropped because of toxicity seen in animal studies.
